Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Human umbilical cord-derived mesenchymal stromal cells improve myocardial fibrosis and restore miRNA-133a expression in diabetic cardiomyopathy

24 Apr 2024

Abstract excerpt

BACKGROUND: Diabetic cardiomyopathy (DCM) is a serious health-threatening complication of diabetes mellitus characterized by myocardial fibrosis and abnormal cardiac function. Human umbilical cord mesenchymal stromal cells (hUC-MSCs) are a potential therapeutic tool for DCM and myocardial fibrosis via mechanisms such as the regulation of microRNA (miRNA) expression and inflammation. It remains unclear, however,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Function and Risk Factors
Share to Mesenchymal stem cell research
Share to Tissue Engineering and Regenerative Medicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38659015
DOI: 10.1186/s13287-024-03715-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Human umbilical cord-derived mesenchymal stromal cells improve myocardial fibrosis and restore miRNA-133a expression in diabetic cardiomyopathyPMID 38659015Read ↗

The role of microRNAs in the pathophysiology, diagnosis, and treatment of diabetic cardiomyopathySemantic proximity Read ↗

MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeuticsSemantic proximity Read ↗

miR133a regulates cardiomyocyte hypertrophy in diabetesSemantic proximity Read ↗

Role of microRNAs in the pathogenesis of diabetic cardiomyopathySemantic proximity Read ↗

Diabetic cardiomyopathy: The role of microRNAs and long non-coding RNAsSemantic proximity Read ↗

MicroRNA: unveiling novel mechanistic and theranostic pathways in diabetic cardiomyopathySemantic proximity Read ↗

Pathogenesis of Diabetic Cardiomyopathy and Role of miRNASemantic proximity Read ↗

Dysregulation of circulating miRNAs promotes the pathogenesis of diabetes-induced cardiomyopathy.Semantic proximity Read ↗

Current Status and Potential Therapeutic Strategies for Using Non-coding RNA to Treat Diabetic CardiomyopathySemantic proximity Read ↗

Diabetic Cardiomyopathy Modelling Using Induced Pluripotent Stem Cell Derived Cardiomyocytes: Recent Advances and Emerging ModelsSemantic proximity Read ↗

Differentially expressed microRNAs and their target genes in the hearts of streptozotocin-induced diabetic miceSemantic proximity Read ↗

Circulating miR-19b and miR-181b are potential biomarkers for diabetic cardiomyopathySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.